Tarceva (Erlotinib Hydrochloride) is a non-chemotherapy drug for the treatment of lung cancer. It is used in the treatment of recurrent NSCLC. It is approved for patients with advanced-stage NSCLC whose cancer…
Drug: Cyramza (Ramucirumab) to Treat NSCLC
Lung Cancer Treatment Cyramza (Ramucirumab) is an approved drug for the treatment of non-small cell lung cancer (NSCLC). It was approved by US FDA as a single agent for treatment of patients…
Drug: Crizotinib for Lung Cancer
Crizotinib FDA Approved Among cancer-related deaths in the United States, lung cancer is the leading cause. FDA has approved the use of Xalkori (crizotinib) for treating patients with non-small cell lung cancer…
Drug: Ceritinib to Treat NSCLC
Ceritinib for Lung Cancer Treatment Ceritinib is a drug for the treatment of lung cancer. It is the generic for the trade chemotherapy drug Zykadia. The drug is a prescription medicine to…
Drug: Avastin (Bevacizumab) to Treat NSCLC
Avastin for Lung Cancer Avastin (Bevacizumab) is a cancer medicine that works to stop the growth and spread of cancer cells. It is used to treat certain types of cancers such as…
Drug: Atezolizumab to Treat NSCLC
Atezolizumab for Lung Cancer Treatment Lung cancer is a leading cause of cancer death at a global level. Atezolizumab, trade name Tecentriq, is indicated for patients with metastatic non-small cell lung cancer…
Drug: Alecensa (Alectinib) to Treat NSCLC
Alecensa (Alectinib) – FDA Approved Lung cancer is one of the leading causes of cancer deaths. Alecensa (alectinib) is an FDA approved drug for the treatment of non-small cell lung cancer (NSCLC)….
Drug: Afinitor (Everolimus) to Treat NSCLC
Everolimus for Lung Cancer Treatment Everolimus in combination with pemetrexed is used in treatment of non-small cell lung cancer (NSCLC). The US brand name of everolimus is Afinitor. It is approved for…